Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.

These trends remained consistent across Aβ+ and Aβ− subgroups, although some comparisons did not reach statistical significance due to limited statistical power.

also in 111,027 other papers